Detection of altered adhesion molecule expression in experimental tumors by a radiolabeled monoclonal antibody

Japanese Journal of Cancer Research

Volumn 88, Issue 12, 1997, Pages 1171-1180

  Saga, Tsuneo ^a   Sakahara, Harumi ^a   Yao, Zhengsheng ^a   Nakamoto, Yuji ^a   Sato, Noriko ^a   Hattori, Noriko ^a   Zhang, Meili ^a   Zhao, Songji ^a   Aoki, Tomokazu ^a   Miyatake, Shin Ichi ^a   Namba, Yuziro ^a   Konishi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Adhesion molecule; Experimental tumor; Integrin 3; Monoclonal antibody; Radioimmunodetection

Indexed keywords

ALPHA3 INTEGRIN; CELL ADHESION MOLECULE; INTEGRIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; DRUG TARGETING; EXPERIMENTAL NEOPLASM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ISOTOPE LABELING; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; TUMOR LOCALIZATION;

EID: 0031456142     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00346.x     Document Type: Article

References (39)

1. Fidler, I. J. and Hanna, M. G., Jr. New approaches to specific and non-specific immunotherapy of established cancer metastases. In "Fundamental Mechanisms in Human Cancer Immunology," ed. J. P. Saunders, pp. 425-437 (1981). Elsevier, North Holland.
2. Liotta, L. A. Cancer cell invasion and metastasis. Sci. Am., Feb., 54-63 (1992).
3. Liotta, L. A. Gene products which play a role in cancer invasion and metastasis. Breast Cancer Res. Treat., 11, 113-124 (1988).
4. Folkman, J. and Shing, Y. Angiogenesis. J. Biol. Chem., 267, 10931-10934 (1992).
5. Hart, I. R. and Saini, A. Biology of tumor metastasis. Lancet, 339, 1453-1457 (1992).
6. Albelda, S. M. Biology of disease: role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest., 68, 4-17 (1993).
7. Schwartz, M. A. Signaling by integrins: implication for tumorigenesis. Cancer Res., 53, 1503-1506 (1993).
8. Bartolazzi, A., Cerboni, C., Full, C., Valentini, C., Natali, P. G., Venturo, I. and Bigotti, A. VLA-3 distribution in normal and neoplastic non-lymphoid human tissues. Pathol. Res. Pract., 189, 387-393 (1993).
9. Natali, P. G., Nicotra, M. R., Di Filippo, F. and Bigotti, A. Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. Br. J. Cancer, 71, 1243-1247 (1995).
10. Natali, P. G., Nicotra, M. R., Bartolazzi, A., Cavaliere, R. and Bigotti, A. Integrin expression in cutaneous malignant melanoma: association of the α3/β1 heterodimer with tumor progression. Int. J. Cancer, 54, 68-72 (1993).
11. Liebert, M., Washington, R., Stein, J., Wedemeyer, G. and Grossman, H. B. Expression of the VLA β1 integrin family in bladder cancer. Am. J. Pathol., 144, 1016-1022 (1994).
12. Albelda, S. M., Mette, S. A., Elder, D. E., Stewart, R., Damjanovich, L., Herlyn, M. and Buck, C. A. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res., 50, 6757-6764 (1990).
13. Friedrichs, K., Ruiz, P., Franke, F., Gille, I., Terpe, H.-J. and Imhof, B. A. High expression level of α6 integrin in human breast cancer is correlated with reduced survival. Cancer Res., 55, 901-906 (1995).
14. Gui, G. P., Wells, C. A., Browne, P. D., Yeomans, P., Jordan, S., Puddefoot, J. R., Vinson, G. P. and Carpenter, R. Integrin expression in primary breast cancer and its relation to axillary nodal status. Surgery, 117, 102-108 (1995).
15. Wayner, E. A., Carter, W. G., Piotrowicz, R. S. and Kunicki, T. J. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J. Cell Biol., 107, 1881-1891 (1988).
16. Takada, Y., Wayner, E. A., Carter, W. G. and Hemler, M. E. Extracellular matrix receptors, ECMRII and ECMRI, for collagen and fibronectin correspond to VLA-2 and VLA-3 in the VLA family of heterodimers. J. Cell. Biochem., 37, 385-393 (1988).
17. Carter, W. G., Wayner, E. A., Bouchard, T. S. and Kaur, P. The role of integrins α2β1 and α3β1 in cell-cell and cell-substrate adhesion of human epidermal cells. J. Cell Biol., 110, 1387-1404 (1990).
18. Fradet, Y., Cordon-Cardo, C., Thomson, T., Daly, M. E., Whitmore, W. F., Jr., Lloyd, K. O., Melamed, M. R. and Old, L. J. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 81, 224-228 (1984).
19. Morhenn, V. B., Schreiber, A. B., Soriero, O., McMillan, W. and Allison, A. C. A monoclonal antibody against basal cells of human epidermis. J. Clin. Invest., 76, 1978-1983 (1985).
20. Peltonen, J., Larjava, H., Jaakkola, S., Gralnick, H., Akiyama, S. K., Yamada, S. S., Yamada, K. M. and Uitto, J. Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. J. Clin. Invest., 84, 1916-1923 (1989).
21. Kondo, S., Miyatake, S., Iwasaki, K., Oda, Y., Kikuchi, H., Zu, Y., Shamoto, M. and Namba, Y. Human glioma-specific antigens detected by monoclonal antibodies. Neurosurgery, 30, 506-511 (1992).
22. Hunter, W. N. and Greenwood, F. C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature, 194, 495-496 (1962).
23. Sakahara, H., Endo, K., Nakashima, T., Koizumi, M., Ohta, H., Torizuka, K., Furukawa, T., Ohmomo, Y., Yokoyama, A., Okada, K., Yoshida, O. and Nishi, S. Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against alpha-fetoprotein. J. Nucl. Med., 26, 750-755 (1985).
24. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J. and Bunn, P. A., Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibody by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods, 72, 77-89 (1984).
25. Scatchard, G. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci., 51, 660-672 (1949).
26. 125I radio-labeled T101 anti-CD5 monoclonal antibody. Nucl. Med. Biol., 17, 201-207 (1990).
27. Saga, T., Endo, K., Akiyama, T., Sakahara, H., Koizumi, M., Watanabe, Y., Nakai, T., Hosono, M., Yamamoto, T., Toyoshima, K. and Konishi, J. Scintigraphic detection of overexpressed c-erbB-2 protooncogene product by a class-switched murine monoclonal anti-c-erbB-2 protein monoclonal antibody. Cancer Res., 51, 990-994 (1991).
28. Kobayashi, H., Sakahara, H., Hosono, M., Shirato, M., Kondo, S., Miyatake, S., Kikuchi, H., Namba, Y., Endo, K. and Konishi, J. Scintigraphic detection of neural-cell-derived small-cell lung cancer using glioma-specific monoclonal antibody. J. Cancer Res. Clin. Oncol., 120, 259-262 (1994).
29. Saga, T., Neumann, R. D., Heya, T., Sato, J., Kinuya, S., Le, N., Paik, C. H. and Weinstein, J. N. Targeting cancer micrometastases with monoclonal antibodies: a binding site barrier. Proc. Natl. Acad. Sci. USA, 92, 8999-9003 (1995).
30. Sands, H., Jones, P. L., Shah, S. A., Palme, D., Vessalla, R. L. and Gallagher, B. M. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Cloeser and renal cell xenografts. Cancer Res., 48, 188-193 (1988).
31. Dvorak, H. F., Nagy, J. A., Dvorak, J. T. and Dvorak, A. M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol., 133, 95-109 (1988).
32. Jain, R. K. and Baxter, L. T. Mechanism of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res., 48, 7022-7032 (1988).
33. Yasoshima, T., Denno, R., Kawaguchi, S., Sato, N., Okada, Y., Ura, H., Kikuchi, K. and Hirata, K. Establishment and characterization of human gastric carcinoma lines with high metastatic potential in the liver: changes in integrin expression associated with the ability to metastasize in the liver of nude mice. Jpn. J. Cancer Res., 87, 153-160 (1996).
34. Mortarini, R., Anichini, A. and Parmiani, G. Heterogeneity for integrin expression and cytokine-related VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins. Int. J. Cancer, 47, 551-559 (1991).
35. Lessey, B. A., Albelda, S., Buck, C. A., Castelbaum, A. J., Yeh, I., Kohler, M. and Berchuck, A. Distribution of integrin cell adhesion molecules in endometrial cancer. Am. J. Pathol., 146, 717-726 (1995).
36. Dedhar, S., Saulnier, R., Nagle, R. and Overall, C. M. Specific alterations in the expression of alpha 3 beta 1 and alpha 6 beta 4 integrins in highly invasive and metastatic variants of human prostate carcinoma cells selected by in vitro invasion through reconstituted basement membrane. Clin. Exp. Metastasis, 11, 391-400 (1993).
37. Weinel, R. J., Rosendahl, A., Pinschmidt, E., Kisker, O., Simon, B. and Santoso, S. The α6-integrin receptor in pancreatic carcinoma. Gastroenterology, 108, 523-532 (1995).
38. Pellegrini, R., Martignone, S., Menard, S. and Colnaghi, M. I. Laminin receptor expression and function in small-cell lung carcinoma. Int. J. Cancer, 8 (Suppl.), 116-120 (1994).
39. Brooks, P. C., Clark, R. A. F. and Cheresh, D. A. Requirement of vascular integrin αvβ3 for angiogenesis. Science, 264, 569-571 (1994).